Roche Singapore Technical Operations Pte Ltd

At Roche, 80,000 people across 150 countries are pushing back the frontiers of healthcare. Working together, we’ve become one of the world’s leading research-focused healthcare groups. Our success is built on innovation, curiosity and diversity, and on seeing each other’s differences as an advantage. To innovate healthcare, Roche has ambitious plans to keep learning and growing – and is seeking people who have the same goals for themselves.

Roche Singapore Technical Operations, formerly Genentech Singapore, is pleased to announce the location of a 1,000-liter microbial manufacturing facility and an 80,000-liter cell culture manufacturing facility in Singapore. These state-of-the-art facilities will produce the bulk drugs Lucentis (ranibizumab), a treatment for age-related macular degeneration, Avastin (bevacizumab), used in the treatment of various types of cancer, and Herceptin (trastuzumab), used for breast cancer.